Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Biogen Gross Profit 2006-2020 | BIIB

Biogen annual/quarterly gross profit history and growth rate from 2006 to 2020. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  • Biogen gross profit for the quarter ending March 31, 2020 was $3.080B, a 6.66% increase year-over-year.
  • Biogen gross profit for the twelve months ending March 31, 2020 was $12.615B, a 6.55% increase year-over-year.
  • Biogen annual gross profit for 2019 was $12.423B, a 6.75% increase from 2018.
  • Biogen annual gross profit for 2018 was $11.637B, a 9.33% increase from 2017.
  • Biogen annual gross profit for 2017 was $10.644B, a 6.76% increase from 2016.
  
Biogen Annual Gross Profit
(Millions of US $)
2019 $12,423
2018 $11,637
2017 $10,644
2016 $9,970
2015 $9,523
2014 $8,532
2013 $6,075
2012 $4,971
2011 $4,582
2010 $4,316
2009 $3,995
2008 $3,696
2007 $2,836
2006 $2,409
2005 $2,049
Biogen Quarterly Gross Profit
(Millions of US $)
2020-03-31 $3,080
2019-12-31 $3,224
2019-09-30 $3,170
2019-06-30 $3,140
2019-03-31 $2,888
2018-12-31 $3,038
2018-09-30 $2,978
2018-06-30 $2,936
2018-03-31 $2,685
2017-12-31 $2,798
2017-09-30 $2,708
2017-06-30 $2,712
2017-03-31 $2,426
2016-12-31 $2,494
2016-09-30 $2,539
2016-06-30 $2,524
2016-03-31 $2,414
2015-12-31 $2,507
2015-09-30 $2,468
2015-06-30 $2,306
2015-03-31 $2,243
2014-12-31 $2,343
2014-09-30 $2,209
2014-06-30 $2,130
2014-03-31 $1,851
2013-12-31 $1,707
2013-09-30 $1,593
2013-06-30 $1,493
2013-03-31 $1,281
2012-12-31 $1,284
2012-09-30 $1,246
2012-06-30 $1,282
2012-03-31 $1,159
2011-12-31 $1,187
2011-09-30 $1,186
2011-06-30 $1,108
2011-03-31 $1,100
2010-12-31 $1,119
2010-09-30 $1,080
2010-06-30 $1,106
2010-03-31 $1,012
2009-12-31 $1,027
2009-09-30 $1,027
2009-06-30 $1,003
2009-03-31 $938
2008-12-31 $968
2008-09-30 $985
2008-06-30 $901
2008-03-31 $841
2007-12-31 $806
2007-09-30 $708
2007-06-30 $689
2007-03-31 $634
2006-12-31 $646
2006-09-30 $637
2006-06-30 $582
2006-03-31 $544
2005-12-31 $520
2005-09-30 $507
2005-06-30 $535
2005-03-31 $488
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $45.724B $14.378B
Biogen is a leading biopharmaceutical company engaged in the research, development and marketing of targeted therapies for the treatment of cancer, autoimmune and inflammatory diseases. The company owns industry leading brands for the treatment of multiple sclerosis, next-generation treatments for hemophilia, and a deep clinical pipeline ranging from Alzheimer's disease, lupus nephritis to neuropathic pain.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $147.997B 16.30
Bristol Myers Squibb (BMY) United States $134.766B 11.26
Gilead Sciences (GILD) United States $94.843B 12.29
CSL (CSLLY) Australia $89.938B 0.00
Vertex Pharmaceuticals (VRTX) United States $76.725B 52.75
Regeneron Pharmaceuticals (REGN) United States $70.449B 27.16
Illumina (ILMN) United States $54.371B 55.87
Seattle Genetics (SGEN) United States $30.385B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $24.107B 0.00
Alexion Pharmaceuticals (ALXN) United States $23.849B 10.25
Incyte (INCY) United States $23.535B 0.00
BioMarin Pharmaceutical (BMRN) United States $23.279B 211.03
Genmab (GMAB) Denmark $23.005B 18.95
Moderna (MRNA) United States $22.860B 0.00
Genmab (GNMSF) Denmark $21.647B 64.27
Alnylam Pharmaceuticals (ALNY) United States $18.506B 0.00
BeiGene (BGNE) Cayman Islands $15.873B 0.00
BioNTech SE (BNTX) Germany $15.286B 0.00
Exact Sciences (EXAS) United States $13.742B 0.00
Sarepta Therapeutics (SRPT) United States $13.270B 0.00
Galapagos (GLPG) Belgium $13.081B 38.48
Bio-Rad Laboratories (BIO.B) United States $12.955B 58.97
ARGENX SE-ADR (ARGX) Netherlands $11.817B 0.00
Horizon Therapeutics Public (HZNP) Ireland $11.210B 27.59
Bio-Techne Corp (TECH) United States $10.473B 69.19
QIAGEN (QGEN) Netherlands $9.923B 28.85
Immunomedics (IMMU) United States $9.594B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.791B 0.00
Guardant Health (GH) United States $8.241B 0.00
Exelixis (EXEL) United States $7.334B 25.72
Ascendis Pharma (ASND) Denmark $6.971B 0.00
Repligen (RGEN) United States $6.553B 114.94
Adaptive Biotechnologies (ADPT) United States $6.193B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.835B 125.56
Novavax (NVAX) United States $5.697B 0.00
Acceleron Pharma (XLRN) United States $5.505B 0.00
Vir Biotechnology (VIR) United States $5.432B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.369B 0.00
Reata Pharmaceuticals (RETA) United States $5.251B 0.00
Mirati Therapeutics (MRTX) United States $5.193B 0.00
Zai Lab (ZLAB) China $5.048B 0.00
Emergent Biosolutions (EBS) United States $4.950B 32.44
MyoKardia (MYOK) United States $4.448B 0.00
MorphoSys AG (MOR) Germany $4.393B 34.07
Blueprint Medicines (BPMC) United States $4.263B 0.00
China Biologic Products (CBPO) China $4.244B 23.59
Global Blood Therapeutics (GBT) United States $4.165B 0.00
Amicus Therapeutics (FOLD) United States $4.066B 0.00
Momenta Pharmaceuticals (MNTA) United States $4.061B 0.00
Halozyme Therapeutics (HALO) United States $3.872B 0.00
NeoGenomics (NEO) United States $3.804B 277.77
Inovio Pharmaceuticals (INO) United States $3.709B 0.00
Bluebird Bio (BLUE) United States $3.692B 0.00
Arena Pharmaceuticals (ARNA) United States $3.346B 0.00
Alkermes (ALKS) Ireland $3.239B 63.77
Deciphera Pharmaceuticals (DCPH) United States $3.173B 0.00
Fate Therapeutics (FATE) United States $2.930B 0.00
Insmed (INSM) United States $2.869B 0.00
Denali Therapeutics (DNLI) United States $2.863B 0.00
Amarin (AMRN) Ireland $2.610B 0.00
PHARMA MAR SA (PHMMF) Spain $2.470B 0.00
Twist Bioscience (TWST) United States $2.237B 0.00
Viela Bio (VIE) United States $2.207B 0.00
UniQure (QURE) Netherlands $2.075B 0.00
Alector (ALEC) United States $1.920B 0.00
Editas Medicine (EDIT) United States $1.913B 0.00
Eidos Therapeutics (EIDX) United States $1.898B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.896B 0.00
Principia Biopharma (PRNB) United States $1.863B 0.00
Ligand Pharmaceuticals (LGND) United States $1.797B 69.98
Forma Therapeutics Holdings (FMTX) United States $1.741B 0.00
Adverum Biotechnologies (ADVM) United States $1.738B 0.00
Zymeworks (ZYME) Canada $1.698B 0.00
I-Mab (IMAB) China $1.673B 0.00
Intra-Cellular Therapies (ITCI) United States $1.665B 0.00
Epizyme (EPZM) United States $1.642B 0.00
Cytokineticsorporated (CYTK) United States $1.601B 0.00
Mersana Therapeutics (MRSN) United States $1.530B 0.00
Sorrento Therapeutics (SRNE) United States $1.529B 0.00
Mesoblast (MESO) Australia $1.509B 0.00
Sangamo Therapeutics (SGMO) United States $1.495B 0.00
Beam Therapeutics (BEAM) United States $1.494B 0.00
Revance Therapeutics (RVNC) United States $1.488B 0.00
NantKwest (NK) United States $1.477B 0.00
Zealand Pharma (ZEAL) Denmark $1.469B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.451B 0.00
REGENXBIO (RGNX) United States $1.449B 0.00
Akcea Therapeutics (AKCA) United States $1.404B 0.00
Zealand Pharma (ZLDPF) Denmark $1.369B 0.00
NGM Biopharmaceuticals (NGM) United States $1.353B 0.00
Arvinas (ARVN) United States $1.328B 0.00
Intellia Therapeutics (NTLA) United States $1.281B 0.00
Coherus BioSciences (CHRS) United States $1.276B 8.91
Adaptimmune Therapeutics (ADAP) United Kingdom $1.223B 0.00
Arcus Biosciences (RCUS) United States $1.164B 0.00
Athenex (ATNX) United States $1.091B 0.00
Compugen (CGEN) Israel $1.090B 0.00
Alcobra (ARCT) United States $1.018B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.986B 0.00
VBI Vaccines (VBIV) United States $0.911B 0.00
Retrophin (RTRX) United States $0.899B 0.00
Dynavax Technologies (DVAX) United States $0.868B 0.00
Myriad Genetics (MYGN) United States $0.868B 44.77
Heska (HSKA) United States $0.847B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.834B 35.83
Cara Therapeutics (CARA) United States $0.830B 0.00
Pharming Group (PHGUF) Netherlands $0.820B 21.83
Intrexon (PGEN) United States $0.775B 0.00
Morphic Holding (MORF) United States $0.766B 0.00
Kadmon Holdings (KDMN) United States $0.752B 0.00
Cellectis S.A (CLLS) France $0.750B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.735B 0.00
Castle Biosciences (CSTL) United States $0.723B 0.00
Frequency Therapeutics (FREQ) United States $0.712B 0.00
Codexis (CDXS) United States $0.708B 0.00
Vericel (VCEL) United States $0.686B 126.75
ZIOPHARM Oncology Inc (ZIOP) United States $0.685B 0.00
Cue Biopharma (CUE) United States $0.670B 0.00
Agenus (AGEN) United States $0.658B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.642B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
Vanda Pharmaceuticals (VNDA) United States $0.632B 5.41
AnaptysBio (ANAB) United States $0.621B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
MiMedx (MDXG) United States $0.591B 0.00
Kala Pharmaceuticals (KALA) United States $0.581B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.566B 0.00
Athersys (ATHX) United States $0.550B 0.00
Syros Pharmaceuticals (SYRS) United States $0.548B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.535B 0.00
Cel-Sci (CVM) United States $0.527B 0.00
Clovis Oncology (CLVS) United States $0.519B 0.00
UROGEN PHARMA (URGN) United States $0.513B 0.00
NextCure (NXTC) United States $0.512B 0.00
Protagonist Therapeutics (PTGX) United States $0.511B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.506B 0.00
Scholar Rock Holding (SRRK) United States $0.502B 0.00
Anika Therapeutics (ANIK) United States $0.501B 16.12
DBV Technologies S.A (DBVT) France $0.494B 0.00
AC Immune SA (ACIU) Switzerland $0.491B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.467B 0.00
MeiraGTx Holdings (MGTX) United States $0.466B 0.00
Geron (GERN) United States $0.443B 0.00
Merus (MRUS) Netherlands $0.443B 0.00
Prothena (PRTA) Ireland $0.436B 0.00
Precision BioSciences (DTIL) United States $0.430B 0.00
Seres Therapeutics (MCRB) United States $0.428B 0.00
BioDelivery Sciences (BDSI) United States $0.428B 22.47
Aeglea BioTherapeutics (AGLE) United States $0.410B 0.00
Puma Biotechnology (PBYI) United States $0.403B 0.00
MannKind (MNKD) United States $0.388B 0.00
CytomX Therapeutics (CTMX) United States $0.385B 0.00
Albireo Pharma (ALBO) United States $0.382B 0.00
Kamada (KMDA) Israel $0.371B 15.44
Avid Bioservices (CDMO) United States $0.369B 0.00
WAVE Life Sciences (WVE) Singapore $0.357B 0.00
ANI Pharmaceuticals (ANIP) United States $0.352B 6.97
Affimed (AFMD) Germany $0.349B 0.00
OSMOTICA PHARM (OSMT) United States $0.328B 0.00
Prometic Life Sciences (LMNL) Canada $0.328B 0.00
PDL BioPharma (PDLI) United States $0.324B 284.00
Starpharma Holdings (SPHRY) Australia $0.313B 0.00
Cellular Biomedicine (CBMG) United States $0.303B 0.00
ChromaDex (CDXC) United States $0.293B 0.00
Spero Therapeutics (SPRO) United States $0.291B 0.00
Abeona Therapeutics (ABEO) United States $0.286B 0.00
Menlo Therapeutics (MNLO) United States $0.285B 0.00
Pfenex (PFNX) United States $0.282B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.275B 0.00
Celldex Therapeutics (CLDX) United States $0.274B 0.00
IBio (IBIO) United States $0.273B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.261B 0.00
Northwest Biotherapeutics (NWBO) United States $0.256B 0.00
IVERIC Bio (ISEE) United States $0.253B 0.00
ADMA Biologics Inc (ADMA) United States $0.250B 0.00
Verastem (VSTM) United States $0.249B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.247B 0.00
Dyadic (DYAI) United States $0.246B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.238B 0.00
Selecta Biosciences (SELB) United States $0.238B 0.00
Five Prime Therapeutics (FPRX) United States $0.236B 0.00
Gritstone Oncology (GRTS) United States $0.234B 0.00
Fortress Biotech (FBIO) United States $0.234B 0.00
HOOKIPA Pharma (HOOK) United States $0.225B 0.00
Pluristem Therapeutics (PSTI) Israel $0.222B 0.00
Aduro Biotech (ADRO) United States $0.218B 0.00
Aptinyx (APTX) United States $0.218B 0.00
XOMA (XOMA) United States $0.214B 0.00
Liquidia Technologies (LQDA) United States $0.214B 0.00
GENFIT S.A (GNFT) France $0.210B 0.00
Strongbridge Biopharma (SBBP) United States $0.208B 0.00
Exicure (XCUR) United States $0.207B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.206B 3.11
Sutro Biopharma (STRO) United States $0.197B 0.00
POXEL SA FRANCE (PXXLF) France $0.190B 0.00
ARAVIVE, INC (ARAV) United States $0.185B 0.00
Bellus Health (BLU) Canada $0.179B 0.00
Trevena (TRVN) United States $0.173B 0.00
Theratechnologies (THTX) Canada $0.170B 0.00
Kindred Biosciences (KIN) United States $0.161B 0.00
CorMedix Inc (CRMD) United States $0.161B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.160B 0.00
Aytu Bioscience (AYTU) United States $0.159B 0.00
Cyclerion Therapeutics (CYCN) United States $0.158B 0.00
VTv Therapeutics (VTVT) United States $0.156B 0.00
Cerecor (CERC) United States $0.155B 0.00
Applied Genetic Technologies (AGTC) United States $0.154B 0.00
Cidara Therapeutics (CDTX) United States $0.153B 0.00
TELA Bio (TELA) United States $0.151B 0.00
Enzo Biochem (ENZ) United States $0.145B 0.00
Celyad SA (CYAD) Belgium $0.143B 0.00
Lumos Pharma (LUMO) United States $0.136B 0.00
VolitionRX (VNRX) United States $0.136B 0.00
Biofrontera AG (BFRA) Germany $0.135B 0.00
PHASEBIO PHARMA (PHAS) United States $0.134B 0.00
Orgenesis (ORGS) United States $0.131B 0.00
Oncobiologics (OTLK) United States $0.131B 0.00
Arbutus Biopharma (ABUS) United States $0.130B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.120B 0.00
Palatin Technologies (PTN) United States $0.119B 3.06
Lineage Cell Therapeutics (LCTX) United States $0.118B 0.00
Celsion (CLSN) United States $0.117B 0.00
Protalix BioTherapeutics (PLX) Israel $0.115B 0.00
AIT Therapeutics (XAIR) United States $0.115B 0.00
AquaBounty Technologies (AQB) United States $0.109B 0.00
Eton Pharmaceuticals (ETON) United States $0.109B 0.00
Checkpoint Therapeutics (CKPT) United States $0.106B 0.00
DiaMedica Therapeutics (DMAC) United States $0.098B 0.00
Cardiff Oncology (CRDF) United States $0.095B 0.00
Windtree Therapeutics (WINT) United States $0.095B 0.00
Cocrystal Pharma (COCP) United States $0.094B 0.00
Unum Therapeutics (UMRX) United States $0.092B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.090B 0.00
Antibe Therapeutics (ATBPF) Canada $0.088B 0.00
Emmaus Life Sciences (EMMA) United States $0.086B 0.00
Organovo Holdings (ONVO) United States $0.084B 0.00
Clearside Biomedical (CLSD) United States $0.084B 0.00
Adocia (ADOCY) France $0.080B 0.00
SESEN BIO, INC (SESN) United States $0.079B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.075B 0.00
Proteostasis Therapeutics (PTI) United States $0.072B 0.00
Catalyst Biosciences (CBIO) United States $0.071B 0.00
AnPac Bio-Medical Science (ANPC) China $0.070B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.069B 0.00
Synlogic (SYBX) United States $0.069B 0.00
Happiness Biotech Group (HAPP) China $0.068B 0.00
Stealth BioTherapeutics (MITO) United States $0.066B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.061B 0.00
Vaccinex (VCNX) United States $0.060B 0.00
Idera Pharmaceuticals (IDRA) United States $0.058B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.057B 0.00
Soligenix (SNGX) United States $0.055B 0.00
CollPlant Holdings (CLGN) Israel $0.054B 0.00
Signal Genetics (MGEN) United States $0.054B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Ecology Coatings (ABVC) United States $0.051B 0.00
Pulmatrix (PULM) United States $0.049B 0.00
Curis (CRIS) United States $0.047B 0.00
Edesa Biotech (EDSA) Canada $0.045B 0.00
Apricus Biosciences (SEEL) United States $0.044B 0.00
AmpliPhi Biosciences (ARMP) United States $0.043B 0.00
Prima BioMed (IMMP) Australia $0.042B 0.00
ATyr Pharma (LIFE) United States $0.040B 0.00
Bionano Genomics (BNGO) United States $0.040B 0.00
Advaxis (ADXS) United States $0.035B 0.00
Acorda Therapeutics (ACOR) United States $0.034B 0.00
Cesca Therapeutics (THMO) United States $0.034B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.033B 0.00
Chanticleer Holdings (SONN) United States $0.032B 0.00
OvaScience (MLND) United States $0.032B 0.00
Spherix (AIKI) United States $0.030B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
Titan Pharmaceuticals (TTNP) United States $0.029B 0.00
Novogen (KZIA) Australia $0.027B 0.00
Alimera Sciences (ALIM) United States $0.027B 0.00
Evogene (EVGN) Israel $0.027B 0.00
BioPharmX (TMBR) United States $0.026B 0.00
Cleveland BioLabs (CBLI) United States $0.026B 0.00
IMMURON (IMRN) Australia $0.026B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.024B 0.00
FORTE BIOSCIENC (FBRX) United States $0.024B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.022B 0.00
Prana Biotechnology (ATHE) Australia $0.022B 0.00
Entera Bio (ENTX) Israel $0.021B 0.00
Genetic Technologies (GENE) Australia $0.020B 0.00
MYOS RENS Technology (MYOS) United States $0.016B 0.00
BioCardia (BCDA) United States $0.016B 0.00
Neuralstem (SNCA) United States $0.013B 0.00
VIVUS (VVUS) United States $0.012B 0.00
AEterna Zentaris (AEZS) United States $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00